Harvard Bioscience Inc Annual Shareholders Meeting Transcript
Good morning.
Good morning, ladies and gentlemen.
Please go ahead, sir. Thank you.
Sorry. Good morning, ladies and gentlemen. I'm John Duke, President and Chief Executive Officer of Harvard Bioscience. It is my pleasure to preside over our company's 2026 annual meeting. I will act as Chairman of this meeting. We are pleased to be once again hosting our meeting using a virtual-only format, which allows our shareholders to participate in the meeting through a convenient online portal. This meeting is officially called to order.
I would like to start by acknowledging the other directors of the company who are present today: Katherine Eade, Robert Gagnon, Seth Benson, Stephen DeNelsky, William Snyder. I would also like to note that Anden Utzinger from our independent auditor, Grant Thornton, and Megan Gates
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
